ArticleACS omega2026
Screening of Xeroprotectants for Efficient Mammalian Cell Structural Preservation in Dry Conditions.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anhydrobiosis, the ability of organisms to survive extreme conditions such as desiccation, may represent a sustainable alternative to liquid-nitrogen (liquid nitrogen)-based cryopreservation once it can be induced in mammalian cells and germplasm. While natural xeroprotectants (e.g., signature peptides of Late Embryogenesis Abundant proteins and tardigrade disordered proteins, and vitamin E) can stabilize cells under drying, their use is limited to the laboratory level due to the high cost of extraction and the incomplete understanding of the molecular mechanisms. Here we employed a multiscale modeling framework spanning quantum mechanics (QM) and molecular dynamics to investigate how these representative xeroprotectants interact with mammalian model membranes (POPC/DMPC) under desiccation and thermal cycling. We found that peptide-based xeroprotectants remain near headgroups and form dehydration-enhanced hydrogen bonds, whereas vitamin E partitions into the acyl chain region. This is consistent with suppressed pore formation in oxidized membranes. Across dry states, xeroprotectants generally increase acyl chain order and membrane rigidity, attenuate area shrinkage, and preserve bilayer thickness homogeneity. Notably, at higher peptide concentrations, chain overordering is mitigated, suggesting a tunable window for formulation. These results provide physicochemical guidelines for designing cost-effective, eco-friendly, and energy-efficient formulations of xeroprotectants and support the rational development of room-temperature preservation strategies with improved translational potential.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.